This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
1h Free Analyst TimeSpeak directly to the analyst to clarify any post sales queries you may have.
Changing lifestyle, obesity, and excessive cholesterol levels are some of the major factors responsible for prevalence of diabetes in people, thereby propelling the demand for diabetes supplements, thus enhancing the diabetes supplements market growth during the forecast period. The global diabetes supplements market is majorly driven by the rising geriatric population across the globe. The increase in the number of chronic disorders across the globe is also a significant factor responsible for rising demand for diabetes supplements. Geriatric population is more likely to suffer from chronic diseases such as diabetes.
They also have high risks of other health conditions. Increasing health & fitness awareness among people after the threatening pandemic is expected to drive the global diabetes supplements market in the upcoming years. There is a growing demand for treatment and prevention of diabetes across the globe. This factor is likely to drive the global diabetes supplements market in the upcoming years.
According to the report, the Global Diabetes Management Supplements market was valued at more than USD 7.82 Billion in 2024, and expected to reach a market size of more than USD 12.60 Billion by 2030 with the CAGR of 8.46% from 2025-2030. Technological advancements in formulation science, delivery formats, and personalized nutrition are expanding the scope of diabetes management supplements, making products more convenient, effective, and consumer friendly. Integrating digital health platforms and mobile applications further enhances patient engagement, enables personalized recommendations, and supports preventive health strategies.
E-commerce expansion and subscription-based distribution models are also streamlining access and improving market penetration across developed and emerging economies. Firms like NOW Foods, Swanson Health Products, Glanbia plc, Vegatot, Glucose Health, Inc., and Life Extension are expanding their footprint by introducing specialized blood sugar management supplements, herbal formulations, and personalized wellness solutions that cater to the growing needs of diabetic patients, health-conscious consumers, and medical practitioners. Their focus on innovation, ingredient transparency, and efficacy-driven formulations enables them to tap into evolving consumer demands for safe and natural glucose-support supplements.
In 2023, GlucoTrust, a market leader, launched a new line of plant-based supplements for insulin resistance. This launch would generate an additional USD 150 million in revenue by 2024. BioBalance introduced a patented supplement containing a blend of bioactive compounds and probiotics. This product is innovative and has boosted sales by 25% in its first quarter. It has positioned BioBalance as a key player in the diabetes supplements market.
Market Drivers
- Rising prevalence of diabetes: the global increase in the number of individuals living with diabetes or pre diabetic conditions is a major growth driver for the supplements market. As sedentary lifestyles, poor diet habits, obesity and aging populations become more pronounced in both developed and developing regions, the demand for adjunctive support through nutritional supplements rises. People and healthcare providers are increasingly seeking supplements that may help improve insulin sensitivity, support blood glucose regulation and reduce complications, making the market for diabetes management supplements stronger.
- Growing awareness of nutritional interventions: Consumers and healthcare professionals are placing greater emphasis on non pharmaceutical strategies for supporting metabolic health, including supplements containing micronutrients, herbal extracts, omega 3 fatty acids and antioxidants. This shift is enhancing uptake of supplements as complementary tools alongside medications, boosting the overall market. Also, as consumers become better informed, they expect formulations that are safe, effective and convenient, which encourages innovation and market expansion.
Market Challenges
- Regulatory complexity: One of the key obstacles for the global diabetes management supplements market is the lack of consistent regulatory frameworks across countries, inconsistent quality standards, and limited standardization of clinical evidence for many products. Because supplements are not always regulated as strictly as pharmaceuticals, questions around safety, efficacy, product labeling and health claims can reduce consumer trust and hinder widespread adoption.
- Pharmaceutical competition: Supplements face strong competition from well established pharmacologic treatments for diabetes that have proven efficacy and often insurance coverage. Consumers diagnosed with diabetes may prioritise medications prescribed by doctors over supplements, and healthcare providers may be hesitant to recommend supplements lacking robust clinical evidence. This dynamic can limit market penetration of supplements as major therapeutic interventions and maintain them in a supportive role, rather than primary therapies.
Market Trends
- Innovation in formulation formats: Manufacturers are increasingly developing advanced supplement formats, multi ingredient combinations, herbal based and plant derived products, as well as formulations that align with consumer preference for “clean label” and convenience. At the same time, there is a growing movement toward personalized nutrition tailoring supplements based on individual metabolic profiles, lifestyle and digital health data which is shaping how the global market evolves.
- Digital health integration and emerging market growth: the global market is being impacted by the rise of e commerce platforms, increased smartphone penetration, and digital health channels that facilitate consumer education and supplement access. Additionally, emerging markets in Asia-Pacific, Latin America and the Middle East are becoming important growth regions due to rising incomes, increased health awareness, and greater availability of supplements. This geographic diversification is a key trend in the global diabetes management supplements market.
Herbal extracts and botanicals are the largest segment in the global diabetes management supplements market due to their natural origin and strong consumer preference for holistic and plant-based therapies.
Herbal extracts and botanicals dominate the global diabetes management supplements market because they combine efficacy, safety, and consumer trust in natural remedies, aligning with the growing preference for holistic healthcare solutions. These ingredients, sourced from plants such as bitter melon, fenugreek, cinnamon, ginseng, and gymnema sylvestre, have been extensively studied for their ability to regulate blood glucose levels, improve insulin sensitivity, reduce oxidative stress, and support overall metabolic health.Unlike synthetic compounds, herbal extracts offer a multifaceted approach, addressing multiple physiological pathways that contribute to diabetes management, making them highly appealing to both patients and healthcare practitioners. Consumer demand for natural products has surged over the past decade due to increased awareness of the side effects associated with long-term synthetic supplement use, and the perception that botanical supplements are safer and gentler on the body. The market benefits from the extensive research and clinical validation conducted by manufacturers and academic institutions, which demonstrates the efficacy of herbal extracts in reducing fasting blood glucose, HbA1c levels, and postprandial sugar spikes.
Major players, such as Herbalife, NOW Foods, Nature’s Way, and Abbott, have focused on integrating these botanicals into convenient formulations like capsules, tablets, powders, and liquid extracts, ensuring easy consumption and adherence. Regulatory frameworks in North America, Europe, and Asia-Pacific, including the U.S. FDA, EFSA, and local health authorities, provide guidance on the quality, safety, and labeling of botanical ingredients, which enhances consumer confidence and market penetration.
Capsules are the largest formulation segment in the global diabetes management supplements market due to their convenience and widespread consumer acceptance.
Capsules enable precise dosing, ensuring that each serving contains a consistent amount of active ingredients such as vitamins, minerals, herbal extracts, and amino acids, which is critical for effective blood sugar management and overall metabolic health. This precision reduces the risk of over- or under-dosing, a factor of particular concern for individuals with diabetes who require strict adherence to supplementation and medication regimens. Capsules provide excellent stability for sensitive ingredients, protecting them from degradation caused by moisture, heat, or light, thereby extending shelf life and maintaining efficacy throughout the product’s lifecycle.Manufacturers also favor capsules because they allow for the combination of multiple active ingredients, including fat-soluble vitamins, minerals, and herbal extracts, in a single dose, enhancing therapeutic effectiveness and improving patient compliance. The popularity of capsules is reinforced by consumer preference for swallowable, tasteless, and odorless forms, as opposed to powders, liquids, or tablets that may have unpleasant flavors or require complex preparation.
Leading supplement companies such as Abbott, Nature Made, and Glanbia have heavily invested in capsule-based formulations for diabetes management, launching specialized products that combine micronutrients with antioxidant-rich herbal extracts to support glycemic control and cardiovascular health. Capsules also align well with global trade and distribution requirements, as they are easy to package, transport, and store, enabling manufacturers to reach international markets efficiently. The growing trend toward preventive healthcare and lifestyle management further drives demand for capsule-based supplements, as consumers increasingly seek convenient solutions to regulate blood sugar, maintain energy levels, and prevent diabetes-related complications.
Multi-ingredient supplements are the largest and fastest-growing segment in the market because they provide comprehensive blood sugar support by combining multiple active nutrients in a single formulation and convenience for consumers.
Unlike single-ingredient supplements, multi-ingredient formulations combine essential vitamins, minerals, herbal extracts, amino acids, and other bioactive compounds that collectively target blood sugar regulation, insulin sensitivity, oxidative stress, and metabolic health. This comprehensive approach is particularly important for diabetes management, where multiple physiological pathways are affected, and patients often require supplementation for various deficiencies and conditions.The inclusion of synergistic ingredients in a single supplement enhances therapeutic efficacy, as compounds like chromium, magnesium, vitamin D, and cinnamon extract work together to improve glucose metabolism, reduce inflammation, and support cardiovascular health, which are critical concerns for diabetic individuals. Consumer demand strongly favors multi-ingredient supplements because they reduce the need to purchase and consume multiple separate products, offering convenience and improved adherence, which is essential for long-term diabetes management.
Major players in the market, such as Abbott, Glanbia, Herbalife, and Nature Made, have increasingly focused on developing multi-ingredient formulations tailored for diabetic patients, leveraging clinical research and scientific validation to ensure efficacy and safety. Multi-ingredient supplements also benefit from advancements in formulation technology, including encapsulation, time-release mechanisms, and bioavailability enhancement, which improve the absorption and stability of combined ingredients. The global supply chain and trade networks enable easy access to high-quality raw materials, including minerals, herbal extracts, and specialized bioactive compounds, allowing manufacturers to create effective, scalable products for international markets.
Offline distribution channels dominate the global diabetes management supplements market due to consumer preference for in-store purchases and accessibility of products through pharmacies and supermarkets.
Pharmacies, health stores, supermarkets, and specialty retail outlets serve as primary touchpoints where consumers can physically inspect products, verify labels, and seek advice from pharmacists or healthcare professionals, which is especially important for individuals managing chronic conditions like diabetes. The offline channel’s prominence is reinforced by established retail networks that ensure wide product availability across urban and rural areas, catering to diverse consumer demographics. Consumers often perceive in-store purchases as safer, given concerns about counterfeit products and the need for clear regulatory compliance, which builds trust in established retail brands.Offline channels also facilitate impulse purchases and repeat buying behavior, as consumers can easily restock their supplements during routine visits to pharmacies or supermarkets. Additionally, in-store marketing, product demonstrations, and educational campaigns by supplement companies help create awareness about specific formulations, multi-ingredient combinations, and newly launched products, driving consumer engagement and loyalty. Regulatory frameworks in key regions, such as the U.S. Food and Drug Administration, the European Food Safety Authority, and local health authorities, ensure that offline-retail products meet stringent labeling, safety, and quality standards, further reinforcing consumer confidence.
The offline distribution network also supports healthcare providers who often recommend supplements directly to patients during consultations, increasing the likelihood of adoption and adherence. Despite the rise of e-commerce, offline channels remain dominant due to cultural preferences, the hands-on nature of supplement selection, and the established habit of purchasing health-related products in person, particularly among older populations and patients with complex health needs.
North America is the largest market for diabetes management supplements due to high diabetes prevalence and widespread consumer adoption of preventive and therapeutic supplements.
North America holds the largest share in the global diabetes management supplements market primarily due to a combination of high diabetes prevalence, growing health awareness, advanced healthcare infrastructure, and a well-established supplement consumption culture. The United States, in particular, has one of the highest rates of diabetes worldwide, with millions of individuals diagnosed with type 1, type 2, and prediabetes conditions, creating substantial demand for products that aid in blood sugar regulation, glycemic control, and overall metabolic health.Consumers in this region are increasingly proactive about preventive healthcare, seeking supplements that can complement their diets, improve energy levels, and reduce the risk of diabetes-related complications such as cardiovascular diseases and neuropathy. North America’s well-developed healthcare system, including widespread access to hospitals, clinics, and pharmacies, facilitates easy availability of diabetes management supplements, often recommended or endorsed by healthcare professionals, which drives trust and adoption. The market is also characterized by a mature retail and distribution network encompassing pharmacies, supermarkets, health stores, and e-commerce platforms, which ensures convenience and accessibility for end users.
Innovation in formulation, including multi-ingredient supplements, capsules, and specialized herbal extracts, is prevalent in North America, with companies like Abbott, Glanbia, Herbalife, and Nature Made introducing clinically validated, research-backed products to cater to a diverse diabetic population. Technological advancements in supplement production, quality control, and packaging further enhance product stability, bioavailability, and consumer trust. Moreover, marketing initiatives focusing on preventive healthcare, lifestyle management, and wellness have successfully educated consumers about the benefits of incorporating dietary supplements into daily routines.
- April 2025: HealthyCell introduced Glucose Support MicroGel™, a next-generation ultra-absorbable gel supplement designed to support healthy glucose levels and overall metabolic wellness.
- March 2025: SIGRID launched a subscription program in the U.S. for its flagship product, Glucose Stabiliser, offering a 22% discount on monthly deliveries.
- December 2024: BOOST® expanded its Glucose Control® product line with the launch of BOOST Glucose Control® Daily Support and BOOST Glucose Control® Mealtime Support dietary supplements.
- January 2024: GNC launched a new Blood Sugar Support supplement formulated to help maintain healthy blood sugar and insulin levels.
- March 2023: Nestlé Health Science launched the Opt2Win program in India, targeting obesity management, a key risk factor for type 2 diabetes, thereby supporting the diabetes supplement market through nutritional interventions and patient-focused weight management.
- January 2023: Diabetic Solutions Inc. acquired NutriCare to expand its product portfolio under the personalized supplements segment. This acquisition would increase NutriCare’s market share by 10% over the next two years.
- February 2022: Vestige launched pre-Gluco Health capsules, a supplement formulated with botanical extracts and micronutrients to support glucose metabolism, improve insulin sensitivity, and help prevent progression from pre-diabetes to diabetes.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Herbalife Nutrition Ltd.
- Amway Corp.
- Abbott Laboratories
- Nestlé Health Science S.A.
- NOW Foods
- Glanbia plc
- Nature's Way Products, LLC
- Swanson Health Products
- Solgar, Inc.
- Ortho Pauher
- VGP Life Innovations LLP
- Ocean Drop Comercio LTDA.
- Fresenius SE & Co. KGaA
- Vitabiotics Ltd.
- Jarrow Formulas, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 187 |
| Published | November 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 7.82 Billion |
| Forecasted Market Value ( USD | $ 12.6 Billion |
| Compound Annual Growth Rate | 8.4% |
| Regions Covered | Global |


